Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification
作者:Pierre Van Antwerpen、Martine Prévost、Karim Zouaoui-Boudjeltia、Sajida Babar、I. Legssyer、Patrick Moreau、Nicole Moguilevsky、Michel Vanhaeverbeek、Jean Ducobu、Jean Nève
DOI:10.1016/j.bmc.2007.11.025
日期:2008.2.15
inhibitors has been conducted using flufenamic acid as a lead compound. Computational docking of the drug and its analogs in the MPO active site was first attempted. Several molecules were then synthesized and assessed using three procedures for the measurement of their inhibiting activity: (i) the taurine assay, (ii) the accumulation of compound II, and (iii) the LDL oxidation by ELISA. Most of the synthesized
髓过氧化物酶(MPO)抑制剂的开发已使用氟苯那酸作为先导化合物进行。首次尝试将药物及其类似物在MPO活性位点进行计算对接。然后使用三种方法合成并评估了几种分子,以测量其抑制活性:(i)牛磺酸测定,(ii)化合物II的积累和(iii)通过ELISA进行的LDL氧化。大多数合成的分子具有与氟芬那酸相同的活性,但是它们均不能抑制MPO依赖性的LDL氧化。然而,实验为合理构想MPO抑制剂提供了一些有用的指示。